$JHX

Australia is 180,000 homes short of its 2029 target. Here's 3 ASX shares that could benefit

Master Builders Australia forecasts Australia will miss its target of 1.2 million new homes by July 2029, with a shortfall rising to 180,200 homes (from 160,000 earlier). It also says 180,500 homes started in 2024-25, about 60,000 below the Accord’s 240,000 goal. The article highlights ASX names James Hardie, Stockland and Mirvac as potential beneficiaries.

Original reporting
Published May 24, 2026, 10:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 24, 2026, 10:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Australia is 180,000 homes short of its 2029 target. Here's 3 ASX shares that could benefit — source image
Decision brief

The 30-second read

$JHXBullishMed
01

Why it matters

The article argues the growing gap plus policy incentives (negative gearing exemption for new builds) creates a multi-year tailwind for ASX-listed housing developers and building materials suppliers.

02

Market read

A macro housing undersupply and new-build incentives are used to justify bullish positioning in three ASX housing-related names.

03

What to watch

Financing conditions, construction input inflation, regulatory permitting delays, and whether policy incentives truly shift buyer behavior toward new builds versus existing stock.

Relevance 7/10Timing: Medium-term: housing shortfall is described as structural and multi-year, so repricing is likely gradual unless policy or construction data accelerates.

Background

Australia targets 1.2m new homes by July 2029, but forecasts show the shortfall widening to 180,200 homes.

Company-level read

Ticker impact

$JHXBullishMedium confidence
Context

James Hardie is highlighted as a fibre-cement and building-products supplier that could benefit if Australia’s housing shortfall drives sustained construction demand.

Expected impact

Moderate positive bias; upside likely depends on whether construction activity and pricing improve versus prior inventory normalization.

Evidence & confidence

The article is sector/macro read-through, but it ties the theme to JHX’s product exposure and cites FY2026 sales growth and pro-forma EBITDA growth targeting.

$SGPBullishMedium confidence
Context

Stockland is positioned as a direct ASX play on the 1.2m-home target via masterplanned communities and land-lease homes.

Expected impact

Moderately positive; near-term sentiment could improve if investors price in higher settlements and operating leverage.

Evidence & confidence

The piece cites specific Q3 FY2026 sales growth, FY2026 settlement targets, and guidance/distribution, but the core catalyst is macro/policy rather than a new company-specific event.

$MGRBullishMedium confidence
Context

Mirvac is framed as benefiting from the housing undersupply and federal negative-gearing exemption changes that favor new-build demand.

Expected impact

Moderate positive; upside sensitivity to how quickly policy-driven demand translates into sales/settlements.

Evidence & confidence

It provides H1 FY2026 sales/settlement and margin recovery metrics plus pipeline restocking, but the main driver is the broader housing/policy backdrop.

Market effects

Reinforces a trade into Australian housing supply-chain beneficiaries: developers (land/settlements) and building materials (cladding/external products).

Primarily Australia-focused demand narrative; could lift sentiment across ASX housing-related names even without company-specific catalysts.

Limited direct global spillover, but it may influence regional construction materials and property sentiment via comparable housing undersupply themes.

Counterpoint

A housing shortfall forecast does not guarantee near-term construction starts; higher costs and long build times could delay revenue recognition and cap upside for developers and materials suppliers.

Key entities

  • Master Builders Australia

    Forecasts the housing shortfall has grown to 180,200 homes and notes stalled projects due to costs/productivity/build times.

  • James Hardie Industries plc

    Fibre cement and external building products supplier; cited FY2026 sales growth and pro-forma EBITDA growth targeting.

  • Stockland Corporation Ltd

    Residential land/developer with masterplanned communities; cited Q3 FY2026 sales growth and FY2026 settlement targets/guidance.

  • Mirvac Group

    Diversified property developer with build-to-rent platform; cited H1 FY2026 residential sales lift and pipeline restocking.

Related articles

$JHXHighAI 9/10

Fitch revises James Hardie outlook on European divestiture

Fitch affirmed James Hardie's 'BBB' rating and revised its outlook to Stable from Negative after the company agreed to sell its European business to Holcim for $980M. The deal, expected to close in 2027, includes the sale of Fermacell and the closure of its European fiber cement business. Fitch expects James Hardie's EBITDA leverage to decrease to 2.5x by FYE 2027, supported by debt paydown and sale proceeds. The European operations contributed 11.5% of revenue and 7.2% of EBITDA in fiscal 2026.

$JHXHighAI 9/10

James Hardie to sell Fermacell for €840m to Holcim

James Hardie will sell its European walling and flooring business, Fermacell, to Holcim for €840m. The company plans to close its European fibre cement business, focusing on North America. Proceeds will repay debt and fund a $250m share repurchase program. Holcim expects the deal to be earnings-accretive from 2027.

$JHXHighAI 9/10

James Hardie ditches Europe, selling out to Holcim in $1.38b deal

James Hardie Industries is selling its Fermacell business in Europe to Holcim for €840 million ($1.38 billion) and exiting the region. The company will focus on its North American operations. According to James Hardie, the deal marks the end of its nine-year ownership of Fermacell.

$JHXHighAI 9/10

James Hardie Selling European Fermacell Business for $980 Million to Holcim

James Hardie Industries is selling its European Fermacell business to Holcim for $980 million, aiming to focus on higher-growth markets. The deal, expected to close in early 2027, will strengthen James Hardie's balance sheet and reduce debt. The company plans to use $600 million of the proceeds to repay debt and authorized a $250 million share repurchase program.

$JHXHighAI 9/10

James Hardie Industries plc: James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million

James Hardie (JHX) is selling its European operations, including Fermacell, to Holcim (HOLN) for €840 million. The company will also close its European fiber cement business. Proceeds will be used to repay debt and fund a $250 million share buyback program. The deal is expected to close in early 2027.